These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 25934513

  • 1. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A, Wu C, Jiang Y, Wang J, Wu J, Yang X, Yang Y.
    J Ethnopharmacol; 2015 Jul 01; 169():219-28. PubMed ID: 25934513
    [Abstract] [Full Text] [Related]

  • 2. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
    Hu X, Rui W, Wu C, He S, Jiang J, Zhang X, Yang Y.
    J Gastroenterol Hepatol; 2014 Jun 01; 29(6):1284-91. PubMed ID: 24329763
    [Abstract] [Full Text] [Related]

  • 3. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
    Wu C, Chen W, Fang M, Boye A, Tao X, Xu Y, Hou S, Yang Y.
    J Ethnopharmacol; 2019 Mar 01; 231():98-112. PubMed ID: 30412748
    [Abstract] [Full Text] [Related]

  • 4. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS.
    J Gastroenterol Hepatol; 2010 Feb 01; 25(2):420-6. PubMed ID: 19793165
    [Abstract] [Full Text] [Related]

  • 5. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
    Rui W, Xie L, Liu X, He S, Wu C, Zhang X, Zhang L, Yang Y.
    J Ethnopharmacol; 2014 Feb 01; 151(1):198-209. PubMed ID: 24247078
    [Abstract] [Full Text] [Related]

  • 6. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts.
    Yang Y, Yang S, Chen M, Zhang X, Zou Y, Zhang X.
    J Ethnopharmacol; 2008 Jul 23; 118(2):264-70. PubMed ID: 18502066
    [Abstract] [Full Text] [Related]

  • 7. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S, Yang Y, Liu X, Huang W, Zhang X, Yang S, Zhang X.
    Br J Dermatol; 2012 Mar 23; 166(3):564-74. PubMed ID: 21967214
    [Abstract] [Full Text] [Related]

  • 8. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C, Chen W, Ding H, Li D, Wen G, Zhang C, Lu W, Chen M, Yang Y.
    Life Sci; 2019 Dec 15; 239():116881. PubMed ID: 31678285
    [Abstract] [Full Text] [Related]

  • 9. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocarcinogenesis via modulating TGF-β/TβR and Imp7/8.
    Wu C, Kan H, Hu M, Liu X, Boye A, Jiang Y, Wu J, Wang J, Yang X, Yang Y.
    Exp Ther Med; 2018 Aug 15; 16(2):1052-1060. PubMed ID: 30112050
    [Abstract] [Full Text] [Related]

  • 10. MAPK inhibitors modulate Smad2/3/4 complex cyto-nuclear translocation in myofibroblasts via Imp7/8 mediation.
    Jiang Y, Wu C, Boye A, Wu J, Wang J, Yang X, Yang Y.
    Mol Cell Biochem; 2015 Aug 15; 406(1-2):255-62. PubMed ID: 25968067
    [Abstract] [Full Text] [Related]

  • 11. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
    Zhang C, Li L, Hou S, Shi Z, Xu W, Wang Q, He Y, Gong Y, Fang Z, Yang Y.
    J Ethnopharmacol; 2021 Oct 28; 279():114350. PubMed ID: 34157326
    [Abstract] [Full Text] [Related]

  • 12. MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells.
    Boye A, Kan H, Wu C, Jiang Y, Yang X, He S, Yang Y.
    Tumour Biol; 2015 May 28; 36(5):3643-51. PubMed ID: 25560488
    [Abstract] [Full Text] [Related]

  • 13. Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway.
    Huang W, Li L, Tian X, Yan J, Yang X, Wang X, Liao G, Qiu G.
    Mol Med Rep; 2015 Apr 28; 11(4):2569-77. PubMed ID: 25435153
    [Abstract] [Full Text] [Related]

  • 14. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
    Zhou Y, Tong X, Ren S, Wang X, Chen J, Mu Y, Sun M, Chen G, Zhang H, Liu P.
    J Ethnopharmacol; 2016 Aug 22; 190():83-90. PubMed ID: 27282665
    [Abstract] [Full Text] [Related]

  • 15. Effects of salvianolic acid-B on TGF-beta 1 stimulated hepatic stellate cell activation and its intracellular signaling.
    Liu C, Liu P, Hu Y, Zhu D.
    Zhonghua Yi Xue Za Zhi; 2002 Sep 25; 82(18):1267-72. PubMed ID: 12425809
    [Abstract] [Full Text] [Related]

  • 16. Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells.
    Lv Z, Song Y, Xue D, Zhang W, Cheng Y, Xu L.
    J Ethnopharmacol; 2010 Nov 11; 132(2):384-92. PubMed ID: 20599490
    [Abstract] [Full Text] [Related]

  • 17. Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways.
    Chen Y, Li H, Li M, Niu S, Wang J, Shao H, Li T, Wang H.
    J Ethnopharmacol; 2017 Mar 22; 200():165-173. PubMed ID: 28232127
    [Abstract] [Full Text] [Related]

  • 18. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H, Dong F, Li G, Niu M, Zhang C, Han Y, He L, Yin P, Wang B, Sang X, Li R, Wang J, Bai Z, Xiao X.
    J Ethnopharmacol; 2018 Jan 10; 210():232-241. PubMed ID: 28864168
    [Abstract] [Full Text] [Related]

  • 19. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
    Perumal N, Perumal M, Halagowder D, Sivasithamparam N.
    Biochimie; 2017 Sep 10; 140():10-19. PubMed ID: 28552397
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
    Wakahara K, Kobayashi H, Yagyu T, Matsuzaki H, Kondo T, Kurita N, Sekino H, Inagaki K, Suzuki M, Kanayama N, Terao T.
    J Cell Biochem; 2004 Oct 15; 93(3):437-53. PubMed ID: 15372629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.